Abstract
The NF1 gene has a TATA-less promoter with a classic CpG island and a 454-bp 5′ untranslated region (UTR). The CpG island is normally unmethylated, with the gene actively transcribed in all tissues examined to date. Although there are no known NF1-causative mutations within the promoter or 5′ UTR, there are reported polymorphisms and rare variants. Some functional analyses and bioinformatic predictions of the promoter and 5′ UTR have been performed, but these regions are not yet extensively characterized. These regulatory sequences are very highly conserved in rodent orthologs, although the upstream gene sequences diverge from the human locus. Very recently, a microRNA locus (miR-4733) was identified 500-bp upstream of the NF1 transcription start site, encoded on the opposite strand. This raises the specter of co-regulation, but that remains to be investigated. The NF1 3′ untranslated region is quite large (3.5 kb) with two polyadenylation sites. The functional significance of (and utility of) these alternative 3′ ends is not known. As with the promoter, there are no known disease-causing mutations in the 3′ UTR. This region has not yet been functionally characterized to identify regulatory sequences, although one microRNA (miR-10b) was found to regulate the NF1 transcript via the 3′ UTR.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bernards A, Snijders AJ, Hannigan GE, Murthy AE, Gusella JF (1993) Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments. Hum Mol Genet 2:645–650.
Bryne JC, Valen E, Tang M-H, Marstrand T, Winther O, da Piedade I, Krogh A, Lenhard B, Sandelin A (2008) JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res 36:D102–D106.
Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866.
Chai G, Liu N, Ma J, Li H, Oblinger JL, Prahalad AK, Chang L-S, Wallace MR, Muir D, Guha A, Phipps RJ, Hock JM, Yu X (2010) MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 101:1997–2004.
Cowley GS, Murthy AE, Parry DM, Schneider G, Korf B, Upadhyaya M, Harper P, MacCollin M, Bernards A, Gusella JF (1998) Genetic variation in the 3′ untranslated region of the neurofibromatosis 1 gene: application to unequal allelic expression. Somat Cell Mol Genet 24:107–119
Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25:1010–1022.
Ebinger M, Senf L, Wachowski O, Scheurlen W (2005) No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood. Pediatr Hematol Oncol 22:83–87
Fishbein L, Eady B, Sanek N, Muir D, Wallace MR (2005) Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells. Cancer Genet Cytogenet 157:181–186.
Haeussler J, Haeusler J, Striebel AM, Assum G, Vogel W, Furneaux H, Krone W (2000) Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3′ untranslated region of the neurofibromin messenger RNA. Biochem Biophys Res Commun 267:726–732.
Hajra A, Martin-Gallardo A, Tarlé SA, Freedman M, Wilson-Gunn S, Bernards A, Collins FS (1994) DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse. Genomics 21:649–652.
Harder A, Rosche M, Reuss DE, Holtkamp N, Uhlmann K, Friedrich R, Mautner VF, von Deimling A (2004) Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. Eur J Cancer 40:2820–2828.
Harder A, Titze S, Herbst L, Harder T, Guse K, Tinschert S, Kaufmann D, Rosenbaum T, Mautner VF, Windt E, Wahlländer-Danek U, Wimmer K, Mundlos S, Peters H (2010) Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5′ untranslated region, exon and intron 1. Twin Res Hum Genet 13:582–594
Hill-Harfe K, Kaplan L, Stalker HJ, Zori RT, Pop R, Scherer G, Wallace MR (2005) Fine mapping of chromosome 17 translocation breakpoints ≥900 kb upstream of SOX9 in acampomelic campomelic dysplasia and a mild, familial skeletal dysplasia. Am J Hum Genet 76:663–671.
Horan MP, Cooper DN, Upadhyaya M (2000) Hypermethylation of the neurofibromatosis type 1 (NF1) gene promoter is not a common event in the inactivation of the NF1 gene in NF1-specific tumours. Hum Genet 107:33–39.
Horan MP, Osborn M, Cooper DN, Upadhyaya M (2004) Functional analysis of polymorphic variation within the promoter and 5′ untranslated region of the neurofibromatosis type 1 (NF1) gene. Am J Med Genet A 131:227–231.
Huang W, Horvath E, Eklund EA (2007) PU.1, Interferon regulatory tactor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells. J Biol Chem 282:6629–6643.
Jenne DE, Tinschert S, Dorschner MO, Hameister H, Stephens K, Kehrer-Sawatzki H (2003) Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse. Genes Chromosomes Cancer 37:111–120.
Kaufmann D, Muller R, Kenner O, Leistner W, Hein C, Vogel W, Bartelt B (2002) The N-terminal splice product NF1-10a-2 of the NF1 gene codes for a transmembrane segment. Biochem Biophys Res Commun 294:496–503.
Kim HR, Roe JS, Lee JE, Hwang IY, Cho EJ, Youn HD (2012) A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH. Biochem Biophys Res Commun 418:682–688.
Lee TK, Friedman JM (2005) Analysis of NF1 transcriptional regulatory elements. Am J Med Genet 137A:130–135.
Ling JQ, Li T, Hu JF, Vu TH, Chen HL, Qiu XW, Cherry AM, Hoffman AR (2006) CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science 312:269–272.
Ling JQ, Hou A, Hoffmann AR (2011) Long-range DNA interactions are specifically altered by locked nucleic acid-targeting of a CTCF binding site. Biochim Biophys Acta 1809:24–33.
Luijten M, Redeker S, van Noesel MM, Troost D, Westerveld A, Hulsebos TJ (2000) Microsatellite instability and promoter methylation as possible causes of NF1 gene inactivation in neurofibromas. Eur J Hum Genet 8:939–945
Mancini DN, Singh SM, Archer TK, Rodenhiser DI (1999) Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 18:4108–4119
Osborn M, Cooper DN, Upadhyaya M (2000) Molecular analysis of the 5′-flanking region of the neurofibromatosis type 1 (NF1) gene: identification of five sequence variants. Clin Genet 57:221–224.
Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, Luts L, Loman N, Jonsson G, Naya H, Hoglund M, Borg A, Rovira C (2011) Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Res 71:78–86.
Purandare SM, Cawthon R, Nelson LM, Sawada S, Watkins WS, Ward K, Jorde LB, Viskochil DH (1996) Genotyping of PCR-based polymorphisms and linkage-disequilibrium analysis at the NF1 locus. Am J Hum Genet 59:159–166
Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M (2010) Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol 220:58–70.
Upadhyaya M, Maynard J, Osborn M, Huson SM, Ponder M, Ponder BA, Harper PS (1995) Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene. J Med Genet 32:706–710
Yang G, Khalaf W, van de Locht L, Jansen JH, Gao M, Thompson MA, van der Reijden BA, Gutmann DH, Delwel R, Clapp DW, Hiebert SW (2005) Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein. Mol Cell Biol 25:5869–5879.
Yu H, Zhao X, Su B, Li D, Xu Y, Luo S, Xiao C, Wang W (2005) Expression of NF1 pseudogenes. Nucleic Acids Res 33:6445–6458
Zou M-X, Butcher DT, Sadikovic B, Groves TC, Yee S-P, Rodenhiser DI (2004) Characterization of functional elements in the neurofibromatosis (NF1) proximal promoter region. Oncogene 23:330–339.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Li, H., Wallace, M.R. (2012). NF1 Gene: Promoter, 5′ UTR, and 3′ UTR. In: Upadhyaya, M., Cooper, D. (eds) Neurofibromatosis Type 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-32864-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-32864-0_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-32863-3
Online ISBN: 978-3-642-32864-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)